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Targeted disruption of Axin2 in mice induces skeletal defects, a phenotype resembling craniosynostosis in humans. Premature fusion of cranial
sutures, caused by deficiency in intramembranous ossification, occurs at early postnatal stages. Axin2 negatively regulates both expansion of
osteoprogenitors and maturation of osteoblasts through its modulation on Wnt/β-catenin signaling. We investigate the dual role of β-catenin to
gain further insights into the skull morphogenetic circuitry. We show that as a transcriptional co-activator, β-catenin promotes cell division by
stimulating its target cyclin D1 in osteoprogenitors. Upon differentiation of osteoprogenitors, BMP signaling is elevated to accelerate the process
in a positive feedback mechanism. This Wnt-dependent BMP signal dictates cellular distribution of β-catenin. As an adhesion molecule, β-catenin
promotes cell–cell interaction mediated by adherens junctions in mature osteoblasts. Finally, haploid deficiency of β-catenin alleviates the Axin2-
null skeletal phenotypes. These findings support a model for disparate roles of β-catenin in osteoblast proliferation and differentiation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Axin; Wnt; β-catenin; BMP; Craniosynostosis; Skull; Suture; Craniofacial morphogenesis; Development abnormalitiesIntroduction
Craniofacial morphogenesis, mediated by a complex reg-
ulatory mechanism, is highly dependent on the patterning
information of emigrant cranial neural crest (CNC) cells
(Francis-West et al., 1998). As a result, the majority of
craniofacial malformations are caused by defects in CNC
(Wilkie and Morriss-Kay, 2001). CNC cells give rise to a wide
variety of tissues and structures, including skull bones (Le
Douarin and Kalcheim, 1999). Lineage tracing/fate mapping
analysis showed that the anterior skull derives mainly from CNC
(Jiang et al., 2002). During skull development, cranial sutures
serve as growth centers for skeletogenesis that is mediated
through intramembranous ossification (Hall, 1990). This
process differs from endochondral ossification in the appendi-⁎ Corresponding author: Fax: +1 585 276 0190.
E-mail address: Wei_Hsu@urmc.rochester.edu (W. Hsu).
1 These two authors contribute equally to this work.
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.10.018cular and axial skeletons, where prior formation of cartilage
templates is required.
Axin2, highly expressed in CNC cells (Jho et al., 2002 and
Yu et al., in press) and developing sutures (Yu et al., 2005a), is
required for skull morphogenesis (Yu et al., 2005a). We
previously demonstrated that targeted disruption of Axin2 in
mice induces premature suture closure (Yu et al., 2005a). This
developmental defect resembles craniosynostosis in humans,
affecting 1 in approximately 2500 individuals (Cohen and
MacLean, 2000). Neural crest (nasal and frontal bones), but not
mesoderm (parietal bones), dependent osteogenesis is particu-
larly sensitive to the loss of Axin2 (Yu et al., 2005a). The
Axin2-null mutant exhibits enhanced expansion of osteopro-
genitors and accelerated intramembranous ossification (Yu et
al., 2005a). Axin2, a negative regulator for the canonical Wnt
pathway (Behrens et al., 1998; Zeng et al., 1997), is required
for down-regulating β-catenin at different stages of osteoblast
development (Yu et al., 2005a). The lack of Axin2 causes a
stimulation of β-catenin signaling that is necessary and
sufficient to promote intramembranous ossification (Yu et al.,
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that β-catenin is required for osteoblast development (Day et
al., 2005; Hill et al., 2005). Coordinate regulation of β-catenin
and Sox9 determines the fate of osteochondroprogenitors
(Akiyama et al., 2004; Kolpakova and Olsen, 2005). In addition
to transducingWnt signals (Logan andNusse, 2004;Moon et al.,
2004), β-catenin plays a critical role in cell adhesion (Bienz,
2005; Gumbiner, 2005; Harris and Peifer, 2005). Cell–cell
interactions mediated by adherens junctions have been shown to
modulate osteoblast function (Stains and Civitelli, 2005).
Previous reports suggested that cadherin–catenin mediated cell
adhesion are involved in musculoskeletal development (Bilezi-
kian et al., 2002; Ferrari et al., 2000; Kawaguchi et al., 2001).
Nevertheless, the exact roles of β-catenin in both the prolifera-
tion and differentiation processes that control calvarial osteo-
blast development remain to be determined.
Bone morphogenetic protein (BMP) (Bilezikian et al., 2002),
which belongs to the transforming growth factor β (TGFβ)
superfamily (Massague, 1998), regulates skeletogenesis through
a cascade of signaling events. Binding of BMP to its receptors
activates the downstream signal transducer called Smad
(Massague et al., 2005). Activated Smad proteins then interact
with transcription factors to control gene expression (Feng and
Derynck, 2005; Whitman and Raftery, 2005). The effects of
BMP can be limited by a group of secreted polypeptides that
prevent BMP signaling by precluding ligand–receptor interac-
tions (Canalis et al., 2003). One of these extracellular
antagonists, Noggin, is induced by BMP to restrict its signaling
activities in a negative feedback fashion (Gazzerro et al., 1998;
Warren et al., 2003). It has been suggested that BMP and Wnt
signaling interact to regulate the development of limb (Soshni-
kova et al., 2003), kidney (Hu and Rosenblum, 2005), tooth and
postnatal hair follicles (Andl et al., 2004). Although BMP and
Wnt pathways play important roles in skeletal development, the
underlying mechanism coordinated by these two pathways
remains elusive.
In this study, we have investigated the involvement of
β-catenin in expansion of osteoprogenitors and maturation of
osteoblasts using the Axin2-null model. In this mutant, only
binding of β-catenin to the Axin-dependent degradation
complex in the cytosol is disrupted. The interaction of
β-catenin with the LEF/TCF transcription and the cadherin-
mediated adhesion complexes remains intact at the Axin2-null
nucleus and plasma membrane, respectively. Our findings
suggest that cellular localization of β-catenin is extremely
important in mediating calvarial osteoblast development. β-
catenin functions as a transcription co-activator and cell
adhesion molecule to promote the proliferation and differentia-
tion processes, respectively. A Wnt dependent BMP signal is
critical to control the activity of β-catenin in a positive
feedback loop. Genetic analysis further reveals that haploid
deficiency of β-catenin alleviates the skull abnormalities
caused by the loss of Axin2. Our findings not only lead to a
model of calvarial osteoblast development mediated by Wnt
and BMP, but also provide new insights into how a single
molecule with multiple functions can dictate complex processes
of lineage-specific development.Materials and methods
Mouse strains
The Axin2 deficient mice and genotyping method were reported previously
(Yu et al., 2005a). For generating the Axin2 deficient mice, genomic DNA
fragments isolated from a P1-phage 129 library were introduced into the pTV0
derived targeting vector (Riethmacher et al., 1995). The 5′ arm contained
sequences from the first intron to the beginning of the second exon, which
encodes the first 2 amino acids of Axin2. The 3′ arm included the end of the
second exon and the third intron. A β-galactosidase cDNA with a nuclear
localization signal was fused to the first codon after the translational initiation
site of Axin2. The Axin2lacZ/+ mutant embryonic stem (ES) cell lines were
generated by electroporation of the targeting vector into E14.1 ES cells. Correct
homologous recombination at the Axin2 locus was confirmed by Southern
blotting. Two independent heterozygous ES cell clones were used to generate
chimeric mice by blastocyst injection as described (Riethmacher et al., 1995). To
ensure the targeted disruption, RT-PCR analyses were used to examine the
expression of Axin2 and lacZ in the Axin+/+ and Axin2−/− calvarial osteoblast
precursors. PCR assays were performed using primers 5′-agtagcgccgtgttagtg-3′
and 5′-atgccatctcgtatgtaggt-3′ for the Axin2 exon2, and primers 5′-cctatcccat-
tacggtcaa-3′ and 5′-taaagcgagtggcaacat-3′ for the lacZ reporter. To generate the
β-catenin-null allele, the Catnbtm2Kem/J strain (Brault et al., 2001) carrying a
floxed allele of β-catenin was crossed with the Zp3-Cre strain (de Vries et al.,
2000). PCR genotyping for the β-catenin allele was performed as described
(Brault et al., 2001). Care and use of experimental animals described in this
work comply with guidelines and policies of the University Committee on
Animal Resources at the University of Rochester.
Primary osteoblast isolation and culture and analyses
Isolation, culture and differentiation of primary osteoprogenitors, as well as
BrdU incorporation, alkaline phosphatase liquid and real-time RT-PCR assays
were reported previously (Yu et al., 2005a,b). Real-time RT-PCR assays were
performed using primers 5′-tggaagtggcccatttagag-3′ and 5′-gcttttctcgtttgtggagc-
3′ for BMP-2, primers 5′-tgagcctttccagcaagttt-3′ and 5′-cttcccggtctcaggtatca-3′
for BMP-4, primers 5′-ctcagaagaaggttggctgg-3′ and 5′-acctcgctcaccttgaagaa-3′
for BMP-6 and primers 5′-gacgccaaagaaccaagag-3′ 5′-tcacagtagtaggcagcatag-3′
for BMP-7. Noggin (500 ng/ml, R&D systems) and ionomycin (2 μM, sigma)
were added in the in vitro cultures as indicated in the text. μCT analysis was
performed using the VIVA CT40 model (Scanco). Histology were performed as
described (Yu et al., 2005a). In brief, skulls were fixed in formaldehyde,
decalcified and paraffin embedded. Samples were sectioned and stained with
hematoxylin/eosin/Orange G for histological evaluation.
Immunostaining and immunoblot
Tissue sections were subject to immunological staining with avidin:
biotinlylated enzyme complex as described (Hsu et al., 2001). Protein extracts
were subject to immunoblotting as described (Hsu et al., 1999). Bound primary
antibodies were detected with horseradish peroxidase-conjugated secondary
antibodies followed by ECL mediated visualization (Amersham) and auto-
radiography, or fluorescein conjugated avidin (Vector Lab) for fluorescent
microscopy. Immunostaining of cultured cells was performed using indirect
fluorescent staining technique. Briefly, cells were fixed with 4% paraformalde-
hyde for 10 min and treated with 0.5% Triton for 15 min and 50 mM glycine for
10 min followed by blocking with the PBS–Triton buffer containing 3% BSA
for 30 min. Samples were then incubated with primary antibody for 1 h and
fluorescent conjugated secondary antibody for 45 min and mounted with
vectashield (Lab Vision) containing propidium iodide. Imagines were analyzed
using a Leica TCS SP spectral confocal microscope. Mouse monoclonal
antibodies α-OBcad (Zymed), α-Ncad (a gift of Masatake Osawa), α-Ecad
(Sigma), α-CDK4 (Cell Signaling) (Lukas et al., 1999) and α-BrdU (Lab
Vision); rabbit polyclonal antibodies α-Cyclin D1 (Lab Vision) (Hall et al.,
1993), α–β-catenin (Lab Vision), α-FGFR1 (Santa Cruz), α-Sox9 (Santa Cruz)
(Sahar et al., 2005) and α-phospho-Smad1/5/8 (Cell signaling) were used as
primary antibodies.
Fig. 1. The loss of Axin2 alters cellular compartmentalization of β-catenin in
osteoprogenitors and stimulates formation of adhesion complex in mature
osteoblasts. Nuclear localization of β-catenin in osteoprogenitors was stimulated
by BIO and the Axin2 disruption. Primary osteoprogenitors isolated from the
Axin2+/+ and Axin2−/− nasal and frontal bones were analyzed for β-catenin
distribution. Confocal microscopy (A–D) revealed that β-catenin was localized to
cytoplasm of the CNC-derived Axin2+/+ osteoprogenitors (A). The presence of
BIO (B) or deletion of Axin2 (C) induced nuclear accumulation ofβ-catenin in the
osteoprogenitors. The addition of Noggin has no effect on β-catenin nuclear
localization in the Axin2−/− osteoprogenitors (D). Inset in panels A and C shows a
superimposed fluorescent image for double labeling of β-catenin in green and
propidium iodide (PI) in red under a low magnification. In mature osteoblasts, β-
catenin is predominantly localized to the plasma membrane. The Axin2+/+ and
Axin2−/− primary osteoprogenitors were induced for maturation by culturing in
differentiation media for 10 days. Confocal microscopy revealed thatβ-catenin (E,
F) and OB-cadherin (G, H) were located to plasma membrane of the Axin2+/+ (E,
G) and Axin2−/− (F, H) differentiated CNC-derived osteoblasts. Note that the
staining of β-catenin and OB-cadherin intensified by the ablation of Axin2. Cells
were stained with β-catenin (A–F) or OB-cadherin (G, H) in green and counter-
stained with PI in red (E–H). Pictures were taken with the same exposure time for
panels A–D and for panels E–H. Scale bars, 40 μm (A–D, G, H); 125 μm (E, F).
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Targeted disruption of Axin2 induces nuclear localization of
β-catenin in osteoprogenitors
Axin2 disruption has a direct effect onβ-catenin in osteoblast
development. This was demonstrated in the Axin2-null suture
during skull morphogenesis at early postnatal stages (Yu et al.,
2005a). Activation of β-catenin was detected in the Axin2−/−
osteogenic fronts and periosteum. However, cellular levels of
activated β-catenin did not increase in the isolated Axin2−/−
osteoprogenitors, but their proliferations were clearly affected
by the mutation (Yu et al., 2005a). The activated form of β-
catenin only showed an obvious accumulation in the differ-
entiated Axin2−/− osteoblasts. This could be due to inability of
the in vitro system to recapitulate the in vivo effects. Alter-
natively, cellular localizations or other functions of β-catenin
that are altered but not detectable by immunoblotting might be
pertinent in calvarial osteoblast development.
β-catenin is also a key component of the adhesion complex,
in addition to regulating the Wnt pathway. Therefore, we
investigated the distribution of β-catenin since it can locate to
different cellular compartments. Using immunostaining and
confocal microscopy, we detected that β-catenin is mainly
localized in the cytoplasm of the CNC-derived Axin2+/+ osteo-
progenitors (percentage, 91%; SD=2.8; n=100) (Fig. 1A). Due
to a requirement of culture for osteoprogenitors under low den-
sities, only images of single cells were shown. However, the
addition of BIO, a pharmacological compound specifically
inhibiting GSK-3β activity causing the stimulation of the
canonical Wnt pathway, induced accumulation of β-catenin in
the nucleus (percentage, 49%; SD=7.8; n=100) (Fig. 1B). In
contrast, β-catenin was predominantly localized to the nuclei of
the CNC-derived Axin2−/− osteoprogenitors (percentage, 89%;
SD=1.4; n=100) (Fig. 1C). These results suggested that the
Axin2 deletion appeared to alter the cellular distribution of β-
catenin. Furthermore, the presence of a BMP antagonist,
Noggin, had no significant effect on nuclear dislocation of β-
catenin in the Axin2−/− osteoprogenitors (percentage, 91%;
SD=2.1; n=100) (Fig. 1D) compared to differentiated osteo-
blasts (see below Fig. 5 for details).
Axin2 deficiency promotes cell–cell interaction mediated by
β-catenin/OB-cadherin in mature osteoblasts
To investigate the role of β-catenin during osteoblast diffe-
rentiation, we examined its distribution in mature osteoblasts
using immunostaining and confocal microscopy. In the diffe-
rentiated Axin2+/+ osteoblasts derived from CNC, a majority of
β-catenin was membrane associated (Fig. 1E). This membrane
distribution of β-catenin was dramatically stimulated by the
Axin2 mutation (Fig. 1F). Because the stimulation was deter-
mined by equivalent fluorescent exposure time optimized for
detection in the Axin2−/− cells, only a weak staining of β-
catenin was shown in the Axin2+/+ mature osteoblast mem-
branes. This is in agreement with the expression studies of β-
catenin by immunoblotting where aberrant elevations of the
Fig. 2. Distribution of cell adhesion molecules in developing skull. Cellular
localizations of adhesion molecules were analyzed by confocal microscopy.
Sections of the 8-day-old Axin2+/+(A, C, E, G) and Axin2−/− (B, D, F, H)
calvaria were stained with β-catenin (A, B, C, D), OB-cadherin (E, F), or N-
cadherin (G, H) in green and counterstained with PI in red. Nuclear localization
of β-catenin (arrowheads) was evident in calvarial osteoprogenitors located to
the Axin2-null periosteum (B), but absent in the wild type counterparts (A). In the
Axin2-null calvarial bones, strong membrane staining of β-catenin (D) and OB-
cadherin (F, asterisks) was detected in mature osteoblasts. Diffused cytosolic
staining was shown in the Axin2+/+ calvarial bones (C, E). N-cadherin showed
weak expression in the cytoplasm of both Axin2+/+ and Axin2−/− (G, H). Scale
bars, 40 μm (A–H).
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differentiated osteoblasts of Axin2−/− (Yu et al., 2005a). The
expression levels of β-catenin did not show a significant change
in the Axin2+/+ and Axin2−/− osteoprogenitors, but the Axin2
deletion only causes dislocation of β-catenin in naive
precursors.
Cell–cell interactions mediated by adherens junctions play a
critical role in promoting osteogenesis (Stains and Civitelli,
2005). Previous reports suggested that cadherins are involved in
osteoblast development (Ferrari et al., 2000; Kawaguchi et al.,
2001). It has been demonstrated that the binding of OBcad to β-
catenin enhances cell–cell adhesion, resulting in morphological
changes of cellular aggregates and stimulating osteoblast and
chondrocyte differentiation (Kii et al., 2004). These findings
strongly support the importance of cell–cell interaction
mediated by adherens junctions in osteoblast differentiation.
To determine if Axin2 deficiency has an effect on cell adhesion
in mature calvarial osteoblasts, we examined expression of
cadherins, which form complexes with β-catenin. OB-cadherin/
cadherin-11 (OBcad), but not N-cadherin (Ncad) and E-cadherin
(Ecad), was more abundantly expressed in the differentiated
primary calvarial osteoblasts (Fig. 1G and data not shown). In
the Axin2−/− osteoblasts, membrane distribution of OBcad was
highly elevated (Fig. 1H).
We next investigated β-catenin distribution in the osteoblast
lineage during skull and suture development in vivo. In the
Axin2+/+ mice at postnatal day 8, we did not observe nuclear
localization of β-catenin in the developing sutures and peri-
osteum that are enriched with osteoblast precursors. β-catenin
was predominantly located to the cytoplasm of mature osteo-
blasts (Fig. 2A). However, the loss of Axin2 caused dislocation
of β-catenin to nuclei of osteoblast precursors in the developing
skull (Fig. 2B). In contrast, prominent staining of β-catenin was
shown at cell–cell junctions of the Axin2−/−mature osteoblasts
(Fig. 2D). At this stage, only diffused cytosolic staining of β-
catenin was observed in the Axin2+/+ mature osteoblasts (Fig.
2C). Our findings suggest that β-catenin might have distinct
functions in osteoprogenitors and mature osteoblasts.
To determine whether cadherin mediated adhesion has a role
in the accelerated intramembranous ossification of Axin2−/−,
cellular distributions of OBcad, Ncad and Ecad were examined.
Diffused localizations of OBcad in the cytoplasm were detected
in the Axin2+/+ calvarial bones at postnatal day 8 (Fig. 2E).
Targeted disruption of Axin2 induced prominent membrane
distribution of OBcad in the developing skulls (Fig. 2F). In
contrast, Ncad (Figs. 2G, H) and Ecad (data not shown) showed
diffused cytoplasmic staining of Axin2+/+ and Axin2−/−
calvarial bones. Consistent with our studies of the in vitro
cultured primary osteoblasts, these results provide evidence that
Axin2 regulates cell–cell interaction through modulation of the
adherens junctions during skull morphogenesis.
Enhanced expansion of osteoprogenitors by β-catenin/cyclin
D1 signaling
Localization of β-catenin to the nucleus led us to
hypothesize that it functions as a transcriptional co-activatorin the osteoprogenitors. β-catenin might promote cell
divisions through regulation of its transcriptional target cyclin
D1, as well as to activate genes required for initiating
differentiation processes in the precursor cells. The nuclear
accumulation of β-catenin is accompanied by stimulated
expression of its direct transcriptional target cyclin D1 in the
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Axin2−/− osteoprogenitors were positive for cyclin D1
whereas only 7% for the wild type (Fig. 3L). This is
consistent with our findings that β-catenin and LEF/TCF
dependent transcription is elevated by the Axin2 deletion (Yu
et al., 2005a). The stimulation of cyclin D1 also led to
stabilization of its target CDK4, which promotes cell cycle
G1/S transition, in the developing skulls (Figs. 3C, D). In the
suture region, the average percentage of osteoblast precursors
positive for CDK4 was 19% and 46% for Axin2+/+ and
Axin2−/−, respectively (Fig. 3L). Immunoblot analyses
further showed an approximately 2.5-fold and 1.5-fold
induction of the steady-state level of cyclin D1 and CDK4
in the Axin2−/− calvarial osteoprogenitors, respectively (Fig.
3K). Together with our previous in vivo findings (Yu et al.,
2005a), the results suggest that the β-catenin/cyclin D1
pathway mediates the enhanced expansion of osteoprogenitors
of the Axin2-null mutants. Because recent studies suggest that
Sox9 is expressed in a subset of precursors that give rise to
osteochondroprogenitors (Akiyama et al., 2005), we then
examined if the Axin2 ablation affects this cell population.
Immunostaining analyses of the Axin2+/+ and Axin2−/−
sutures detected an expansion of the Sox9-expressing
precursors at postnatal days 0 and 8 (Figs. 3E–H). The
average percentage of osteoprogenitors positive for Sox9 was
8% and 66% for Axin2+/+ and Axin2−/−, respectively (Fig.
3L). However, there was no obvious difference in Sox9
expression during chondrogenesis of the Axin2+/+ and
Axin2−/− nasal cartilages (Figs. 3I, J). Immunoblot analyses
further showed that the Axin2 mutation causes an approxi-
mately 2.0-fold induction of the steady-state level of Sox9 in
the calvarial osteoprogenitors (Fig. 3K). These data imply
that Wnt signaling regulates accumulation of this Sox9-
expressing precursor cell population during calvarial osteo-
blast development.
Alteration of BMP signaling by Axin2 deficiency
Craniosynostosis induced by Axin2 deficiency is mediated
through its effects on cell proliferation and differentiationFig. 3. Expansion of osteoblast precursors affected by Axin2 deficiency.
Immunostaining of cyclin D1 (brown staining and blue counterstaining) showed
an enhanced expression in the Axin2−/− osteoprogenitors (B), compared to the
Axin2+/+ cells (A). Osteoblast precursors in developing mouse skull were
analyzed by immunohistochemistry (C–H). Sections were immunostained with
antibodies (brown) and counterstained with hematoxylin (blue). The deletion of
Axin2 resulted in stimulation of CDK4 at postnatal day 8 (C, D). The Sox9-
expressing precursor population was highly increased by the Axin2 inactivation
at newborn (E, F) and postnatal day 8 (G, H). The Sox9 expression in the
newborn nasal cartilage of Axin2+/+(I) and Axin2−/− (J) did not show any
noticeable difference. The osteoblast precursors that are positive (brown) and
negative (blue) for immunostaining analyses (A–D and G–H) were counted to
obtain the percentage of positive cells. The graph shows the average percentage
of the positive stained cells in five independent experiments (L). Immunoblot
analyses revealed quantitative alterations in the expression of cyclinD1 (CycD1),
CDK4 and Sox9 in the Axin2+/+ and Axin2−/− calvarial osteoprogenitors (K).
The level of Actin serves as a loading control. Scale bars, 200 μm (A, B); 50 μm
(C–J).during calvarial osteoblast development. To further elucidate the
mechanism underlying the Wnt-mediated osteoblast deve-
lopment, it is necessary to investigate the interaction of β-
catenin with important skeletal regulators, especially in the
differentiation processes. The important role of BMP in
skeletogenesis led us to test whether this signal transduction
pathway is affected by the Axin2 deletion. We first examined if
the phosphorylated/active form of Smad1/5/8, key molecules to
mediating the downstream effects of BMP, accumulated in the
Axin2−/− skulls. Immunostaining analyses revealed that
Fig. 4. BMP signaling is induced in the Axin2-null mutants during calvarial
osteoblast development. Immunohistochemical staining of the 8-day-old Axin2
+/+ (A) and Axin2−/− (B) sutures with the α-phospho-Smad1/5/8 antibody
reveals stimulation of BMP signaling by the Axin2 deletion (brown staining and
blue counterstaining). The graph shows the average percentage of the Axin2+/+
and Axin2−/− osteoblast precursors of the suture region positive for phospho-
Smad1/5/8 in five independent experiments (D). (C) CNC-derived osteoblast
precursors, isolated from the Axin2+/+ and Axin2−/− littermates, were cultured
in differentiation media for up to 12 days. Lysates were isolated at different
differentiation days as indicated. Immunoblot analysis with α-phospho-Smad1/
5/8 (PSmad1/5/8) antibodies shows that BMP signaling was stimulated in the
Axin2 mutants during osteoblast differentiation. The level of Actin was also
analyzed as a control for protein content of the lysates. Quantitative real-time RT-
PCR analyses were performed to examine expression of BMP-2 (E) and BMP-6
(F) during the course of osteoblast differentiation. The graphs represent the
expression levels (in arbitrary units, Y axes) of BMP-2 and BMP-6 during the
course of osteoblast differentiation. Scale bars, 50 μm (A, B).
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8-day-old Axin2−/− sutures (Figs. 4A, B, D). During osteoblast
differentiation in vitro, phosphorylated Smad1/5/8 proteins
were accumulated in the CNC-derived osteoblasts in the
Axin2 mutants (Fig. 4C). In three independent experiments,
inactivation of Axin2 caused an abrupt activation of the BMP
pathway. This result provides a mechanism by which alkaline
phosphatase and osteogenic markers, the downstream targets
of BMP, were stimulated in the Axin2-null mutants (Yu et al.,
2005a). To examine if the Axin2 mutation also had an effect
on the expression of BMP ligands, quantitative real-time RT-
PCR analyses were performed. Our data suggested that BMP-
2 (Fig. 4E) and BMP-6 (Fig. 4F), but not BMP-4 and BMP-7
(data not shown), were stimulated in the Axin2−/−
osteoblasts. These data imply a role of BMP signaling in
calvarial osteoblast development mediated by the Wnt-Axin
regulatory network. Stimulation of BMP signaling might be a
key step for initiating the β-catenin mediated differentiation
processes.A Wnt dependent BMP signal mediates cell–cell interaction by
promoting membrane distribution of β-catenin
To determine if the adhesive role of β-catenin is required for
its function in the mature osteoblasts, we used ionomycin to test
this possibility. Ionomycin treatment is known to disrupt cell–
cell adhesion by inducing cleavage of cadherins, leading to
dislocation of the bound β-catenin (Ito et al., 1999; Marambaud
et al., 2002). The addition of ionomycin altered the prominent
distribution of β-catenin in the Axin2−/− membrane (Figs. 5A,
B). Membrane localization of OBcad was also prevented by the
presence of ionomycin (Figs. 5D, E). These data demonstrated
that the presence of ionomycin has a strong effect on the
formation of the OBcad/β-catenin complex in the differentiated
Axin2−/− osteoblasts. The dislocation of adhesion molecules to
the cytoplasm by ionomycin suggests that cell adhesion plays a
role in mature osteoblasts where β-catenin functions to mediate
cell–cell contacts. Because of a potential role of BMP in the
Axin2 mediated osteoblast differentiation, we next examined if
BMP signaling is involved in β-catenin localization. Indeed,
inhibition of BMP signaling by Noggin greatly reduces the
membrane accumulation of β-catenin (Fig. 5C) and OBcad
(Fig. 5F), suggesting that BMP signaling might regulate cell–
cell interaction during calvarial osteoblast differentiation. Note
that fluorescent exposure time was optimized for the detection of
β-catenin and OBcad in the Axin2−/− cells without ionomycin
or Noggin in the same set of experiments. Pictures were taken
under the same parameter so that a relatively weaker staining
was shown in Figs. 5B, C, E and F. Our data demonstrated that
the prominent membrane accumulation of β-catenin and OBcad
caused by the Axin2 deletion in the differentiated cells is
inhibited by Noggin. Therefore, a BMP signal, initially induced
by Wnt signaling due to the loss of Axin2 (Fig. 4), dictates β-
catenin localization to the plasma membrane of mature
osteoblasts (Fig. 5). These findings suggest a distinct role of
β-catenin as an adhesion molecule in mature osteoblasts.
The role of BMP in β-catenin mediated osteoblast
differentiation
To test if the Wnt dependent BMP signal plays a role in
osteoblast proliferation, Noggin was included in the culture
media. Primary osteoblast precursors isolated from nasal and
frontal bones of the Axin2+/+ and Axin2−/− were grown in
culture media for an in vitro proliferation assay. Inhibition of
BMP by Noggin has no obvious effects on expansion of the
Axin2+/+ and Axin2−/− osteoprogenitors in vitro as deter-
mined by the BrdU labeling method (Fig. 6A). This is consistent
with the evidence that the presence of Noggin did not interfere
with β-catenin nuclear localization in the Axin2−/− osteopro-
genitors (Fig. 1D). BMP signaling is not involved in expansion
of osteoprogenitors mediated by Wnt. The β-catenin/cyclin D1
pathway mediates the enhanced expansion of osteoprogenitors
of the Axin2-null mutants in a BMP-independent fashion.
However, cellular distribution of β-catenin in the differ-
entiated cells was strikingly altered in the presence of Noggin
(Fig. 5). We therefore hypothesized that BMP signaling plays a
Fig. 5. Noggin inhibits membrane accumulations of β-catenin and OBcad caused by the Axin2 disruption in mature osteoblasts. Confocal microscopy revealed
that β-catenin (A) and OBcad (D) were predominantly located to plasma membrane of the Axin2−/− differentiated CNC-derived osteoblasts. Cells were stained
with β-catenin (A–C) or OBcad (D–F) in green and counterstained with propidium iodide (PI) in red. Pictures were taken under the same parameter optimized
for detection in the Axin2−/− cells. Addition of ionomycin (Iono) or Noggin (NG) disrupts the membrane localization of β-catenin (B, C) and OB-cadherin (E, F) in the
Axin2-null mutants. Scale bars, 125 μm (A–C); 40 μm (D–F).
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signaling. To determine if antagonizing BMP interfered with
osteoblast differentiation of the Axin2 mutants, Noggin was
added to the differentiation media at day 5. The inhibitory effect
of Noggin on BMP signaling drastically reduced the accelerated
osteoblast differentiation in primary cultures of the CNC-
derived Axin2-null osteoblasts, as determined by alkaline
phosphatase liquid assays (Fig. 6C). The presence of NogginFig. 6. Effects of Noggin on osteoblast development. Primary osteoblast precursors iso
culture media for in vitro BrdU incorporation assay (A). The percentage of proliferati
in a total of >1000 cells. The addition of Noggin had no obvious effect on expansion
osteoprogenitors of Axin2+/+ (B) and Axin2−/− (C–E) were analyzed for osteoblast
indicated. Noggin (B–D) and Ionomycin (E) were present after day 5 of differentiation
deficiency in a dosage dependent manner as determined by alkaline phosphatase activ
in three independent experiments.caused an approximately 3.5-fold decrease in the alkaline
phosphatase activity at differentiation day 9. This was
apparently specific to the presence of Noggin because the
inhibitory effect worked in a dosage dependent fashion (Fig.
6D). A similar effect of Noggin on osteoblast differentiation
was also observed in the Axin2+/+ cells (Fig. 6B). The
antagonizing effect of Noggin might be attributed to its ability
to dislocate β-catenin and to alter the cadherin mediated cell–lated from nasal and frontal bones of the Axin2+/+ and Axin2−/−were grown in
ng osteoprogenitors was obtained by analyzing BrdU positive and negative cells
of both the Axin2+/+ and Axin2−/− osteoprogenitors. (B–E) The CNC-derived
differentiation using alkaline phosphatase liquid assay at different time points as
. Noggin inhibits the accelerated intramembranous ossification caused by Axin2
ity at differentiation day 10 (D). Graphs, except for panel D, represent the average
Fig. 7. Alleviation of the Axin2-null defects by haploid deficiency of β-catenin.
β-catenin+/− mice were crossed into the Axin2-null background to obtain the
Axin2−/−; β-catenin+/− mice. Haploid deficiency of β-catenin alleviates the
Axin2−/− skull abnormalities at 4 weeks (A, B). The arrows indicate the sutures
(black, metopic suture; white, jugum limitans) that lie between nasal (N) and
frontal (F) bones. Theses sutures disappearing in the Axin2−/− mutants (A) are
apparent in the Axin2−/−; β-catenin+/− littermates (B). μCT analyses reveal
that the suture closure defects (white long and short arrows, jugum limitans;
black long and short arrows, coronal suture) caused by Axin2 deficiency (C)
were alleviated by haploid deficiency of β-catenin (D). Histology shows that
metopic sutures, prematurely fused in the Axin2-null mutants (E, long arrows),
remain patent in the Axin2−/−; β-catenin+/− mice (F, short arrows) at 4 weeks.
Scale bars, 3 mm (A, B); 5 mm (C, D); 200 μm (E, F).
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catenin is critical to mediate osteoblast differentiation. Iono-
mycin treatment was induced at day 5 of osteoblast differentia-
tion in vitro. The presence of ionomycin dramatically interfered
with osteoblast differentiation of the Axin2 mutants (Fig. 6E).
By differentiation days 9 and 12, the addition of ionomycin
resulted in approximately 6.1-fold and 8.0-fold decreases in the
alkaline phosphatase activity, respectively. Our studies provide
compelling evidence that cell adhesion mediated by β-catenin is
required for osteoblast differentiation. In addition, BMP
signaling, initially stimulated by Axin2 deficiency, appears to
work in a positive feedback mechanism to control the osteoblast
differentiation processes through modulation of β-catenin
compartmentalization.
Haploid deficiency of β-catenin alleviates craniofacial bone
defects caused by Axin2 deficiency
Our findings suggested that β-catenin plays important yet
disparate roles in different stages of calvarial osteoblast
development. We therefore crossed the Axin2-null mutants
with mice carrying a β-catenin-null allele to definitely assess
the requirement of β-catenin in skull morphogenesis mediated
by Axin2. The anterior skull abnormalities induced by the
targeted disruption of Axin2 were alleviated in the Axin2−/−;
β-catenin+/− mutants (Fig. 7, n=4/9). Haploid deficiency of
β-catenin was able to prevent the premature suture closure
(including jugum limitans, coronal and metopic sutures)
caused by the Axin2 deletion. These cranial sutures disappear-
ing in the Axin2-null mutants are evident in the Axin2−/−;
β-catenin+/− littermates (Figs. 7A–D). The metopic suture
remains patent in the Axin2−/−; β-catenin+/− mice at postnatal
day 28 (Figs. 7E, F). These data demonstrated a genetic inter-
action of Axin2 and β-catenin in skull and suture development.
Our previous results showed that Axin2 regulates both cell
proliferation and differentiation during calvarial osteoblast
development (Yu et al., 2005a). To determine if haploid
deficiency of β-catenin affects expansion of osteoprogenitors
in the Axin2−/− mice, expression of a mitotic marker Ki67 was
analyzed to identify proliferating cells. Decreasing the levels of
β-catenin drastically diminished the number of mitotic cells in
the Axin2-null sutures at postnatal day 8 (Figs. 8A, B). The
average percentage of proliferating cells was reduced by ∼1.8-
fold, and to a level similar to that in the wild type (Axin2+/+)
mice (Fig. 8C) (Yu et al., 2005a). Therefore, haploid deficiency
of β-catenin induced an inhibitory effect on enhanced expansion
of the Axin2−/− osteoprogenitors. We next examined if haploid
deficiency of β-catenin in the Axin2-null mice affected
skeletogenesis that could be characterized by the expression of
an osteogenic marker FGFR1 (Yu et al., 2005a). Indeed, the
presence of the FGFR1-expressing cells was decreased from
∼46% in the Axin2−/−; β-catenin+/+ sutures to ∼12% in the
Axin2−/−; β-catenin+/− sutures (Figs. 8D, E, H). This was also
accompanied by a diminution in BMP signaling as determined
by the expression of phosphorylated Smad1/5/8 (Figs. 8F, G).
The average percentage of osteoprogenitors positive for phopho-
Smad1/5/8 were 55% and 24% for Axin2−/−; β-catenin+/+ andAxin2−/−; β-catenin+/−, respectively (Fig. 8H). Immunoblot
analysis further showed that the expression of FGFR1 and
phospho-Smad1/5/8 was reduced in the Axin2−/−;β-catenin+/−
osteoprogenitors (Fig. 8I). In these mutants, the Wnt dependent
stimulation of BMP signaling caused by Axin2 deficiency was
prevented by partial deletion of β-catenin. Our results strongly
argue for a requirement of β-catenin in the Axin2-null calvarial
osteoblast phenotypes. Stimulation of BMP signaling caused by
the Axin2 deletion absolutely depends on β-catenin. This is
consistent with the inhibitory effects of Noggin on the
accelerated maturation process of the Axin2−/− osteoblasts
(Fig. 6C). A positive feedback loop exists between Wnt and
BMP signaling during skull morphogenesis. β-catenin with two
disparate roles exerts its effects on regulating expansion of
osteoprogenitors and maturation of osteoblasts.
Discussion
Emerging evidence suggests that the canonical Wnt pathway
is crucial for bone and cartilage formation (Akiyama et al.,
Fig. 8. Requirement of β-catenin in the Axin2 mediated osteoblast proliferation
and differentiation. Immunostaining of Ki67 detects cells undergoing active
divisions in the 8-day-old Axin2−/− (A) and Axin2−/−; β-catenin+/− (B)
sutures. A reduced level of β-catenin causes a decrease in the presence of the
mitotic osteoprogenitors stimulated by Axin2 deficiency. In the suture regions,
osteoblast precursors that are positive (brown) and negative (blue) for Ki67 were
counted to measure the proliferation effects. At least 8 different regions from
four different mice were analyzed to obtain the average percentage of Ki67
positive (Ki67+) cells at postnatal day 8 (C). The skeletogenesis was
characterized by expression of FGFR1 (D, E) and phospho-Smad1/5/8 (F, G).
Sections were immunostained with α-FGFR1 or α-phospho-Smad1/5/8 anti-
body (brown) and counterstained with hematoxylin (blue). In the Axin2−/−; β-
catenin+/− suture, a reduction of the FGFR1-expressing cells is evident at
postnatal day 17 and a diminution in BMP signaling is detected at postnatal
day 28. The graph shows in the suture region the average percentage of the
Axin2−/−; β-catenin+/+ and Axin2−/−; β-catenin+/− osteoblast precursors
positive for phospho-Smad1/5/8 (PSmad) and FGFR1 in five independent
experiments (H). Immunoblot analyses revealed that haploid deficiency of β-
catenin induced a quantitative change of the FGFR1 and phospho-Smad1/5/8
levels in the Axin2−/− calvarial osteoprogenitors (I). The level of Actin was also
analyzed as a control for protein content. Scale bars, 50 μm (A, B, D, E, F, G).
Fig. 9. Model for calvarial osteoblast development mediated by Wnt signaling.
β-catenin is located to the cytoplasm of resting osteoprogenitors. An active Wnt
signal promotes cell cycle entry by inducing nuclear localization of β-catenin
(β-Cat) and activation of cyclin D1 (CycD1). During osteoblast differentiation,
membrane distribution and stimulation of β-catenin and OBcad are mediated
through a mechanism involving BMP signaling. Membrane accumulations of β-
catenin and OBcad induce cell–cell interaction to promote the differentiation
process. Noggin has an inhibitory effect on osteoblast differentiation, but not
proliferation. Both Axin2 and Noggin regulate the Wnt and BMP pathways in a
negative feedback loop, respectively. β-catenin, which functions as a
transcriptional co-activator and a cell adhesion molecule, plays distinct roles
in osteoblast proliferation and differentiation, respectively. Axin2, whose
deficiency affects dislocation of β-catenin in osteoprogenitors and formation of
adherens junctions in mature osteoblasts, negatively modulates both develop-
mental processes.
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Gong et al., 2001; Hill et al., 2005; Kolpakova and Olsen, 2005;
Li et al., 2005; Little et al., 2002). A growing list of molecules,regulating β-catenin signaling, has been linked to various
skeletal diseases (Hartmann, 2006). However, the exact role of
β-catenin in sequential steps of bone development remains
elusive. As a result of accelerated intramembranous ossifica-
tion, targeted disruption of Axin2 induces premature suture
closure (Yu et al., 2005a). Axin2 apparently regulates expansion
of osteoprogenitors and maturation of osteoblasts through its
modulation on the canonical Wnt pathway (Yu et al., 2005a).
Using the Axin2-null mouse model, we investigated the exact
functions and downstream signaling effects of β-catenin in
osteoblast proliferation and differentiation. The results lead us
to the following theory (Fig. 9). The enhanced proliferation is
mediated by stimulation of a Wnt target gene cyclin D1 to
promote cell divisions in osteoprogenitors. BMP signaling,
elevated by Axin2 deficiency, is intimately involved in the
Axin2/β-catenin-dependent osteogenesis. Inhibition of BMP by
Noggin has no effects on nuclear accumulation of β-catenin as
well as expansion of osteoprogenitors in the Axin2 mutants.
However, Noggin strongly affects osteoblast maturation by
regulating adherens junctions. During osteoblast differentiation,
a BMP-dependent event, initially activated by Wnt, is required
to promote cell–cell interaction by stimulating membrane
accumulations of β-catenin and OBcad. Thus, it results in
accelerated intramembranous ossification occurring in the
Axin2−/− skulls. Disturbance of cell–cell interaction interferes
with osteoblast differentiation, suggesting that adherens junc-
tions play a significant role in the maturation processes. The
presence of Noggin not only disrupts membrane distribution
and stimulation of β-catenin and OBcad, but also represses
osteoblast differentiation. These findings strongly support our
model for distinct roles of β-catenin at different stages of
calvarial osteoblast development (Fig. 9). β-catenin regulates
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expansion of osteoprogenitors and maturation of osteoblasts,
respectively.
Haploid deficiency of β-catenin alleviates the skull defects
caused by Axin2 deficiency. The data reveal an absolute
requirement of β-catenin in the Axin2 mediated skull
morphogenesis. Haploid deficiency of β-catenin prevents
premature fusion of the Axin2-null sutures by interfering with
the calvarial osteoblast development. In the Axin2−/−; β-
catenin+/− mutants, BMP signaling is reduced that places BMP
downstream of β-catenin in osteoblast development. This is
consistent with stimulation of phosphorylated Smad1/5/8 by the
Axin2 deletion. On the other hand, Noggin was only able to
inhibit the differentiation but not proliferation abnormalities,
caused by Axin2 deficiency. Noggin interferes with membrane
accumulations of β-catenin, suggesting that it is regulated by
BMP during osteoblast maturation. Therefore, these two
pathways appear to work in a feedback regulatory mechanism
(Fig. 9). Initial β-catenin activation is responsible for stimulat-
ing the β-catenin/cyclin D1 pathway to enhance proliferation in
a BMP-independent fashion. Nuclear localization of β-catenin
then turns on BMP signaling that induces a second event of
β-catenin activation upon osteoblast differentiation. This BMP-
dependent signal facilitates the maturation processes by
promoting cell–cell interaction mediated by β-catenin/OBcad.
The functions of β-catenin can also be molecularly distinct.
In C. elegans, there are three different β-catenin gene products
for adhesion and signaling functions (Korswagen et al., 2000).
BAR-1 mediates Wnt signaling by forming a transcription
complex with POP-1 (TCF/LEF). HMP-2 interacts exclusively
with cadherin. WRM-1 is involved in a divergent Wnt pathway
where it regulates POP-1 indirectly. Nevertheless, there is no
evidence for multiple β-catenin gene products in vertebrates.
This raises the possibility that β-catenin utilizes its distinct
functions in regulating osteoblast development. Previous
genetic analyses demonstrated that β-catenin is essential for
different stages of skeletal development (Day et al., 2005; Hill
et al., 2005). However, the nature of these studies could not
distinguish which function of β-catenin is critically involved.
The exact roles of β-catenin remain unclear because it is a
multifunctional protein, which is involved in cellular responses
including Wnt signaling (Logan and Nusse, 2004; Moon et al.,
2004) and cell adhesion (Bienz, 2005; Gumbiner, 2005; Harris
and Peifer, 2005). Only the binding of β-catenin to the
degradation complex is disrupted in the Axin2-null mice.
These mutants provide an excellent model to investigate the
functional involvement of β-catenin in the adhesion and
transcription complexes. Our results demonstrated that β-
catenin utilizes its disparate roles to control expansion of
osteoprogenitors and maturation of osteoblasts in different
contexts. They also provide evidence for how one molecule
with multiple cellular functions can regulate the proliferation
and differentiation processes of single lineage-specific devel-
opment. Although prior studies suggested that distinct mole-
cular forms of β-catenin possess preferential binding affinity to
adhesion, transcription and degradation complexes to ensure
proper tissue architecture and cell-fate decisions (Brembeck etal., 2004; Gottardi and Gumbiner, 2004), details of such
mechanisms regulated in these microenvironments remain to be
elucidated. Further investigations of our system might gain new
insights into these mechanistic regulations.
The cadherin–catenin mediated cell adhesion has been shown
to promote osteogenesis (Ferrari et al., 2000; Stains and Civitelli,
2005). Our data strongly support the importance of cell–cell
interaction mediated by adherens junctions in osteoblast
differentiation. OBcad, but not Ncad or Ecad, is specifically
stimulated in the Axin2-null mutants. Similar to the Axin2-null
mutants, the loss of OBcad caused defects in skeletal develop-
ment that occurred preferentially in the mouse skull (Kawaguchi
et al., 2001). It has been suggested that Ncad, activated by BMP-
2, is a direct target of Sox9 in chondrogenesis (Panda et al.,
2001). In human craniosynostosis with FGFR2 mutation, Ncad
overexpression plays a role in premature suture closure (Muenke
and Schell, 1995). Therefore, promoting cell adhesion by
stimulating the cadherin–catenin complex formation might be
a key part of the skull morphogenetic signaling network, as well
as other processes in musculoskeletal development.
FGF signaling plays a key role in skull morphogenesis and
craniosynostosis (Ornitz and Marie, 2002) although the mechan-
ism by which FGF interacts with Wnt and BMP remains to be
illustrated. Expression of two potential Wnt downstream targets
FGF4 and FGF18 is elevated by Axin2 deficiency during
osteoblast differentiation (Yu et al., 2005a). In the Axin2-null
sutures, increased numbers of the FGFR1-expressing cells are
evident (Yu et al., 2005a). This process depends on β-catenin as
shown in the Axin2−/−; β-catenin+/− mice. Previous studies
suggested that FGFmight induce BMP signaling by inhibiting the
BMP-dependent activation of Noggin (Warren et al., 2003). It is
possible that FGF acts in between Wnt and BMP to orchestrate
skull morphogenesis. The exact role of FGF signaling in the
hierarchy of skull signaling cascade and in the calvarial osteoblast
developmental processes remains to be determined. Future studies
focused on delineating the skull morphogenetic circuitry that
regulates tissue architecture and cell-fate decisions promise
important insights into the molecular and cellular bases of
craniosynostosis.
Acknowledgments
We thank Edward Puzas, Regis O’Keefe, Tzong-Jen Sheu,
Hani Awad, Laura Yanoso and Sara Lim for technical
assistance, Masatake Osawa for reagents and Anthony Mirando
for critical reading of the manuscript. This work was supported
by grants from the National Institutes of Health (CA106308 and
DE015654) to W.H.
References
Akiyama, H., et al., 2004. Interactions between Sox9 and beta-catenin control
chondrocyte differentiation. Genes Dev. 18, 1072–1087.
Akiyama, H., et al., 2005. Osteo-chondroprogenitor cells are derived from Sox9
expressing precursors. Proc. Natl. Acad. Sci. U. S. A. 102, 14665–14670.
Andl, T., et al., 2004. Epithelial Bmpr1a regulates differentiation and
proliferation in postnatal hair follicles and is essential for tooth development.
Development 131, 2257–2268.
308 B. Liu et al. / Developmental Biology 301 (2007) 298–308Behrens, J., et al., 1998. Functional interaction of an axin homolog, conductin,
with beta-catenin, APC, and GSK3beta. Science 280, 596–599.
Bennett, C.N., et al., 2005. Regulation of osteoblastogenesis and bone mass by
Wnt10b. Proc. Natl. Acad. Sci. U. S. A. 102, 3324–3329.
Bienz, M., 2005. beta-catenin: a pivot between cell adhesion andWnt signalling.
Curr. Biol. 15, R64–R67.
Bilezikian, J.P., et al., 2002. Principles of Bone Biology. Academic Press, San
Diego.
Brault, V., et al., 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-
mediated deletion results in dramatic brain malformation and failure of
craniofacial development. Development 128, 1253–1264.
Brembeck, F.H., et al., 2004. Essential role of BCL9-2 in the switch between
beta-catenin's adhesive and transcriptional functions. Genes Dev. 18,
2225–2230.
Canalis, E., et al., 2003. Bone morphogenetic proteins, their antagonists, and the
skeleton. Endocr. Rev. 24, 218–235.
Cohen, M.M., MacLean, R.E., 2000. Craniosynostosis: Diagnosis, Evaluation,
and Management. Oxford Univ. Press, New York.
Day, T.F., et al., 2005. Wnt/beta-catenin signaling in mesenchymal progenitors
controls osteoblast and chondrocyte differentiation during vertebrate
skeletogenesis. Dev. Cell 8, 739–750.
de Vries, W.N., et al., 2000. Expression of Cre recombinase in mouse oocytes: a
means to study maternal effect genes. Genesis 26, 110–112.
Feng, X.H., Derynck, R., 2005. Specificity and versatility in TGF-signaling
through smads. Annu. Rev. Cell Dev. Biol. 21, 659–693.
Ferrari, S.L., et al., 2000. A role for N-cadherin in the development of the
differentiated osteoblastic phenotype. J. Bone Miner. Res. 15, 198–208.
Francis-West, P., et al., 1998. Signalling interactions during facial development.
Mech. Dev. 75, 3–28.
Gazzerro, E., et al., 1998. Bone morphogenetic proteins induce the expression of
noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest.
102, 2106–2114.
Glass II, D.A., et al., 2005. Canonical Wnt signaling in differentiated osteoblasts
controls osteoclast differentiation. Dev. Cell 8, 751–764.
Gong, Y., et al., 2001. LDL receptor-related protein 5 (LRP5) affects bone
accrual and eye development. Cell 107, 513–523.
Gottardi, C.J., Gumbiner, B.M., 2004. Distinct molecular forms of beta-catenin are
targeted to adhesive or transcriptional complexes. J. Cell Biol. 167, 339–349.
Gumbiner, B.M., 2005. Regulation of cadherin-mediated adhesion in morpho-
genesis. Nat. Rev., Mol. Cell Biol. 6, 622–634.
Hall, B.K., 1990. Bone. Telford Press, Caldwell, NJ.
Hall, F.L., et al., 1993. Two potentially oncogenic cyclins, cyclin A and cyclin
D1, share common properties of subunit configuration, tyrosine phosphor-
ylation and physical association with the Rb protein. Oncogene 8,
1377–1384.
Harris, T.J., Peifer, M., 2005. Decisions, decisions: beta-catenin chooses
between adhesion and transcription. Trends Cell Biol. 15, 234–237.
Hartmann, C., 2006. AWnt canon orchestrating osteoblastogenesis. Trends Cell
Biol. 16, 151–158.
Hill, T.P., et al., 2005. Canonical Wnt/beta-catenin signaling prevents
osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727–738.
Hsu, W., et al., 1999. Identification of a domain of Axin that binds to the serine/
threonine protein phosphatase 2A and a self-binding domain. J. Biol. Chem.
274, 3439–3445.
Hsu, W., et al., 2001. Impaired mammary gland and lymphoid development
caused by inducible expression of Axin in transgenic mice. J. Cell Biol. 155,
1055–1064.
Hu, M.C., Rosenblum, N.D., 2005. Smad1, beta-catenin and Tcf4 associate in a
molecular complex with the Myc promoter in dysplastic renal tissue and
cooperate to control Myc transcription. Development 132, 215–225.
Ito, K., et al., 1999. Calcium influx triggers the sequential proteolysis of
extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-
catenin from cell–cell contacts. Oncogene 18, 7080–7090.
Jho, E.H., et al., 2002. Wnt/beta-catenin/Tcf signaling induces the transcription
of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22,
1172–1183.
Jiang, X., et al., 2002. Tissue origins and interactions in the mammalian skull
vault. Dev. Biol. 241, 106–116.Kawaguchi, J., et al., 2001. Targeted disruption of cadherin-11 leads to a
reduction in bone density in calvaria and long bone metaphyses. J. Bone
Miner. Res. 16, 1265–1271.
Kii, I., et al., 2004. Cell–cell interaction mediated by cadherin-11 directly
regulates the differentiation of mesenchymal cells into the cells of the
osteo-lineage and the chondro-lineage. J. Bone Miner. Res. 19,
1840–1849.
Kolpakova, E., Olsen, B.R., 2005. Wnt/beta-catenin—a canonical tale of cell-
fate choice in the vertebrate skeleton. Dev. Cell 8, 626–627.
Korswagen, H.C., et al., 2000. Distinct beta-catenins mediate adhesion and
signalling functions in C. elegans. Nature 406, 527–532.
Le Douarin, N., Kalcheim, C., 1999. The Neural Crest. Cambridge Univ. Press,
Cambridge, UK.
Li, X., et al., 2005. Dkk2 has a role in terminal osteoblast differentiation and
mineralized matrix formation. Nat. Genet. 37, 945–952.
Little, R.D., et al., 2002. A mutation in the LDL receptor-related protein 5 gene
results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet.
70, 11–19.
Logan, C.Y., Nusse, R., 2004. The Wnt signaling pathway in development and
disease. Annu. Rev. Cell Dev. Biol. 20, 781–810.
Lukas, C., et al., 1999. Immunohistochemical analysis of the D-type cyclin-
dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
Hybridoma 18, 225–234.
Marambaud, P., et al., 2002. A presenilin-1/gamma-secretase cleavage releases
the E-cadherin intracellular domain and regulates disassembly of adherens
junctions. EMBO J. 21, 1948–1956.
Massague, J., 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67,
753–791.
Massague, J., et al., 2005. Smad transcription factors. Genes Dev. 19,
2783–2810.
Moon, R.T., et al., 2004. WNT and beta-catenin signalling: diseases and
therapies. Nat. Rev., Genet. 5, 691–701.
Muenke, M., Schell, U., 1995. Fibroblast-growth-factor receptor mutations in
human skeletal disorders. Trends Genet. 11, 308–313.
Ornitz, D.M., Marie, P.J., 2002. FGF signaling pathways in endochondral and
intramembranous bone development and human genetic disease. Genes Dev.
16, 1446–1465.
Panda, D.K., et al., 2001. The transcription factor SOX9 regulates cell cycle and
differentiation genes in chondrocytic CFK2 cells. J. Biol. Chem. 276,
41229–41236.
Riethmacher, D., et al., 1995. A targeted mutation in the mouse E-cadherin gene
results in defective preimplantation development. Proc. Natl. Acad. Sci.
U. S. A. 92, 855–859.
Sahar, D.E., et al., 2005. Sox9 neural crest determinant gene controls
patterning and closure of the posterior frontal cranial suture. Dev. Biol.
280, 344–361.
Soshnikova, N., et al., 2003. Genetic interaction between Wnt/beta-catenin and
BMP receptor signaling during formation of the AER and the dorsal–ventral
axis in the limb. Genes Dev. 17, 1963–1968.
Stains, J.P., Civitelli, R., 2005. Cell–cell interactions in regulating osteogenesis
and osteoblast function. Birth Defects Res. C. Embryo Today 75, 72–80.
Warren, S.M., et al., 2003. The BMP antagonist noggin regulates cranial suture
fusion. Nature 422, 625–629.
Whitman, M., Raftery, L., 2005. TGFbeta signaling at the summit. Development
132, 4205–4210.
Wilkie, A.O., Morriss-Kay, G.M., 2001. Genetics of craniofacial development
and malformation. Nat. Rev., Genet. 2, 458–468.
Yu, H.M., et al., 2005a. The role of Axin2 in calvarial morphogenesis and
craniosynostosis. Development 132, 1995–2005.
Yu, H.M., et al., 2005b. Development of a unique system for spatiotemporal and
lineage-specific gene expression in mice. Proc. Natl. Acad. Sci. U. S. A. 102,
8615–8620.
Yu, H. M., et al., in press. Impaired neural development caused by inductible
expression of Axin in transgenic mice. Mech. Dev. doi:10.1016/j.
mod.2006.10.002.
Zeng, L., et al., 1997. The mouse Fused locus encodes Axin, an inhibitor of the
Wnt signaling pathway that regulates embryonic axis formation. Cell 90,
181–192.
